References
- PelaezBCampilloJALopez-AsenjoJASubizaJLCyclophosphamide induces the development of early myeloid cells suppressing tumor cell growth by a nitric oxide-dependent mechanismJ Immunol2001166116608661511359814
- ManSBocciGFranciaGAntitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking waterCancer Res200262102731273512019144
- NakamuraYKunitohHKubotaKRetrospective analysis of safety and efficacy of low-dose docetaxel 60 mg/m2 in advanced non-small cell lung cancer patients previously treated with platinum-based chemotherapyAm J Clin Oncol200326545946414528070
- GhiringhelliFLarmonierNSchmittECD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curativeEur J Immunol200434233634414768038
- SalemMLAl-KhamiAAEl-NaggarSADiaz-MonteroCMChenYColeDJCyclophosphamide induces dynamic alterations in the host microenvironments resulting in a Flt3 ligand-dependent expansion of dendritic cellsJ Immunol201018441737174720083664
- MaeshimaYColoradoPCTorreADistinct antitumor properties of a type IV collagen domain derived from basement membraneJ Biol Chem200027528213402134810766752
- HeYJiangYLiYJ19-peptide, a fragment of tumstatin, inhibits the growth of poorly differentiated gastric carcinoma cells in vitro and in vivoJ Gastroenterol Hepatol201025593594120546447
- HuanYHeYLiuMA comparative study of tumor-suppression effects of enterotoxin B and Chalone 19-peptide on experimental gastric carcinomaHepatogastroenterology2009568927027519453073
- IkezawaYNakazawaMTamuraCTakahashiKMinamiMIkezawaZCyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivityJ Dermatol Sci200539210511215899580
- GhiringhelliFMenardCPuigPEMetronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsCancer Immunol Immunother200756564164816960692
- CaoYZhaoJYangZCD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapyClin Immunol20101361212920338811
- MaeshimaYYerramallaULDhanabalMExtracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesisJ Biol Chem200127634319593196811399763
- HamanoYKalluriRTumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growthBiochem Biophys Res Commun2005333229229815979458
- LiYJSunLCHeYThe anti-tumor properties of two tumstatin peptide fragments in human gastric carcinomaActa Pharmacol Sin20093091307131519701238
- PorterAGJanickeRUEmerging roles of caspase-3 in apoptosisCell Death Differ1999629910410200555
- GrutterMGCaspases: key players in programmed cell deathCurr Opin Struct Biol200010664965511114501
- HishikawaKNakakiTFujiiTConnective tissue growth factor induces apoptosis via caspase 3 in cultured human aortic smooth muscle cellsEur J Pharmacol20003921–2192210748267
- Fresno-VaraJACasadoEde CastroJCejasPBelda-IniestaCGonzalez-BaronMPI3 K/Akt signalling pathway and cancerCancer Treat Rev200430219320415023437
- SalmenaLCarracedoAPandolfiPPTenets of PTEN tumor suppressionCell2008133340341418455982
- StambolicVSuzukiAde la PompaJLNegative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTENCell199895129399778245
- MaehamaTDixonJEThe tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphateJ Biol Chem19982732213375133789593664
- ZhengHCLiYLSunJMGrowth, invasion, metastasis, differentiation, angiogenesis and apoptosis of gastric cancer regulated by expression of PTEN encoding productsWorld J Gastroenterol2003981662166612918097